Comprehensive analysis of 5-Aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  van Bemmel, Dana M ^a   Boffetta, Paolo ^b,c   Liao, Linda M ^a   Berndt, Sonja I ^a   Menashe, Idan ^a   Yeager, Meredith ^a   Chanock, Stephen ^a   Karami, Sara ^a   Zaridze, David ^d   Matteev, Vsevolod ^d   Janout, Vladimir ^e   Kollarova, Hellena ^e   Bencko, Vladimir ^f   Navratilova, Marie ^g   Szeszenia Dabrowska, Neonilia ^h   Mates, Dana ⁱ   Slamova, Alena ^f   Rothman, Nathaniel ^a   Han, Summer S ^a   Rosenberg, Philip S ^a   Brennan, Paul ^b,c   Chow, Wong Ho ^a   Moore, Lee E ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^d N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^e PALACKÝ UNIVERSITY   (Czech Republic)

^f CHARLES UNIVERSITY   (Czech Republic)

^g MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^h NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

ⁱ NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; LEAD; PORPHOBILINOGEN SYNTHASE;

ADULT; AGED; ALLELE; AMINOLEVULINIC ACID GENE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; SINGLE NUCLEOTIDE POLYMORPHISM; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; ENVIRONMENTAL EXPOSURE; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; KIDNEY TUMOR; MIDDLE AGED; RISK;

ADULT; AGED; CARCINOMA, RENAL CELL; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KIDNEY NEOPLASMS; LEAD; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PORPHOBILINOGEN SYNTHASE;

EID: 79960576472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020432     Document Type: Article

References (34)

1. U.S. Environmental Protection Agency (1999) Integrated Risk Information System (IRIS) on Lead and Compounds (Inorganic). National Center for Environmental Assessment, Office of Research and Development, Washington, DC.
2. Goyer RA, (1990) Lead toxicity: from overt to subclinical to subtle health effects. Environ Health Perspect 86: 177-181.
3. Needleman HL, (1990) Low level lead exposure: a continuing problem. Pediatr Ann 19: 208-214.
4. Pirkle JL, Schwartz J, Landis JR, Harlan WR, (1985) The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am J Epidemiol 121: 246-258.
5. Louis ED, Applegate L, Graziano JH, Parides M, Slavkovich V, et al. (2005) Interaction between blood lead concentration and delta-amino-levulinic acid dehydratase gene polymorphisms increases the odds of essential tremor. Mov Disord 20: 1170-1177.
6. International Agency for Research on Cancer (2006) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Inorganic and organic lead compounds, vol 87. Lyons, France.
7. Onalaja AO, Claudio L, (2000) Genetic susceptibility to lead poisoning. Environ Health Perspect 108 (Suppl 1): 23-28.
8. Wetmur JG, Kaya AH, Plewinska M, Desnick RJ, (1991) Molecular characterization of the human delta-aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 49: 757-763.
9. Goering PL, Fowler BA, (1987) Regulatory roles of high-affinity metal-binding proteins in mediating lead effects on delta-aminolevulinic acid dehydratase. Ann N Y Acad Sci 514: 235-247.
10. Claudio L, Lee T, Wolff MS, Wetmur JG, (1997) A murine model of genetic susceptibility to lead bioaccumulation. Fundam Appl Toxicol 35: 84-90.
11. Boffetta P, Fontana L, Stewart P, Zaridze D, Szeszenia-Dabrowska N, et al. (2011) Jan 8.[Epub ahead of print] Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma. Occupational and Environmental Medicine.
12. World Health Organization (1990) International Classification of Diseases for Oncology, tenth revision, 2nd Edition Geneva, Switzerland World Health Organization.
13. Brennan P, van der Hel O, Moore LE, Zaridze D, Matveev V, et al. (2008) Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe. Br J Cancer 99: 1912-1915.
14. Hsu CC, Chow WH, Boffetta P, Moore L, Zaridze D, et al. (2007) Dietary risk factors for kidney cancer in Eastern and Central Europe. Am J Epidemiol 166: 62-70.
15. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
16. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, et al. (2006) SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34: D617-621.
17. Mannetje A, Fevotte J, Fletcher T, Brennan P, Legoza J, et al. (2003) Assessing exposure misclassification by expert assessment in multicenter occupational studies. Epidemiology 14: 585-592.
18. Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, et al. (2008) International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 17: 3081-3089.
19. Wacholder S, Rothman N, Caporaso N, (2002) Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 11: 513-520.
20. Teixeira PC, Onuki J, Medeiros MH, Dornemann D, Di Mascio P, (2001) DNA damage by 3,6-dihydropyrazine-2,5-dipropanoic acid, the cyclic dimerization product of 5-aminolevulinic acid. Biol Chem 382: 913-918.
21. Onuki J, Teixeira PC, Medeiros MH, Dornemann D, Douki T, et al. (2002) Is 5-aminolevulinic acid involved in the hepatocellular carcinogenesis of acute intermittent porphyria? Cell Mol Biol (Noisy-le-grand) 48: 17-26.
22. Silbergeld EK, (2003) Facilitative mechanisms of lead as a carcinogen. Mutat Res 533: 121-133.
23. Battistuzzi G, Petrucci R, Silvagni L, Urbani FR, Caiola S, (1981) delta-Aminolevulinate dehydrase: a new genetic polymorphism in man. Ann Hum Genet 45: 223-229.
24. Fujita H, Nishitani C, Ogawa K, (2002) Lead, chemical porphyria, and heme as a biological mediator. Tohoku J Exp Med 196: 53-64.
25. Wetmur JG, Lehnert G, Desnick RJ, (1991) The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 56: 109-119.
26. Fleming DE, Chettle DR, Wetmur JG, Desnick RJ, Robin JP, et al. (1998) Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. Environ Res 77: 49-61.
27. Bergdahl IA, Grubb A, Schutz A, Desnick RJ, Wetmur JG, et al. (1997) Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol 81: 153-158.
28. Schwartz BS, Lee BK, Stewart W, Ahn KD, Springer K, et al. (1995) Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol 142: 738-745.
29. Rajaraman P, Stewart PA, Samet JM, Schwartz BS, Linet MS, et al. (2006) Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 15: 2514-2520.
30. Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM, (2006) Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect 114: 1538-1541.
31. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P, (2005) Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 114: 101-108.
32. Tielemans E, Heederik D, Burdorf A, Vermeulen R, Veulemans H, et al. (1999) Assessment of occupational exposures in a general population: comparison of different methods. Occup Environ Med 56: 145-151.
33. Valladares Ayerbes M, Aparicio Gallego G, Diaz Prado S, Jimenez Fonseca P, Garcia Campelo R, et al. (2008) Origin of renal cell carcinomas. Clin Transl Oncol 10: 697-712.
34. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, (2002) Cancer Incidence in Five Continents Vol. VIII. IARC Scientific Publication No.155. Lyon, France.